Results 191 to 200 of about 26,340 (266)

C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report. [PDF]

BMC Nephrol
Yanagidani H, Maeoka Y, Yoshida M, Ueda M, Kumano M, Takahashi A, Okubo A, Kato N, Maruyama S, Masaki T.   +9 more
europepmc   +1 more source

Contemporary Guideline-Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study. [PDF]

J Am Heart Assoc
Greene SJ, Adam A, Schmedt N, Carlsen C, Brand M, Davies E, Jouaville Abrouk LS, Prochaska JH, Tran P, Alhamdow A.   +9 more
europepmc   +1 more source

Baroreflex Activation Therapy in a Patient With Transthyretin Amyloid Cardiomyopathy. [PDF]

JACC Case Rep
Khanna NR, DenDulk A, Atteya G, Talati SN.   +3 more
europepmc   +1 more source

Developing neural stem cell-based treatments for neurodegenerative diseases [PDF]

, 2014

core   +1 more source

Sacubitril/valsartan improves nocturia in hypertensive patients: a pilot study. [PDF]

Transl Androl Urol
Kitta T, Kakizaki H, Kihara H.
europepmc   +1 more source

Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients. [PDF]

Biomed Rep
Rampengan DDCH, Surya SC, Tjandra KC, Lele JAJMN, Rampengan SH, Kadariswantiningsih IN, Idrisov B, Idrisova A, Empitu MA.   +8 more
europepmc   +1 more source

Sacubitril/valsartan as add-on to standard therapy in patients with heart failure: A randomized controlled trial. [PDF]

World J Exp Med
Dhawan R, Mittal R, Kumar A, Laller KS, Gill PS, Rag A, Mittal N.   +6 more
europepmc   +1 more source

Treatment gaps in guideline-directed medical therapy for HFrEF in Singapore: findings from a multicentre retrospective cohort study. [PDF]

BMJ Open
Senanayake S, Lee ASY, Graves N, Win PPS, Lee A, Lau YH, Hausenloy DJ, Yeo KK, Chan MY, Wong RCC, Loh SY, Sim KLD, Chow W, Tan KB, Kularatna S.   +14 more
europepmc   +1 more source

Impact of Pre-Existing Cardiovascular and Metabolic Conditions on the Development of Heart Failure After Paclitaxel Therapy: Real-World Study Based on a Nationwide Claims Database in Japan. [PDF]

Circ Rep
Iwane S, Tanaka M, Miyamoto T, Nishida K, Hasebe S, Kikuta M, Tsuji T.   +6 more
europepmc   +1 more source